UNSPSC 51142519: Brasofensine

This classification denotes an antiparkinsonian agent with the molecular formula C16H20Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1YP2S94RVH, chemically known as 3-beta-(3,4-dichlorophenyl)-1-alpha-h, 5-alpha-h-tropane-2-alpha-carboxaldehyde (e)-(o-methyloxime). but generally known as brasofensine, which bears US NIH Compound Identifier 9554198. Brasofensine most often comes in base, maleate, and sulfate forms.

UNSPSC 51142519 Brasofensine is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single opportunity in the recent record—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—concerns emergency medical supplies and community health products, not the pharmaceutical compound brasofensine. The mismatch suggests either a tagging error in the source data or that this Commodity code does not reflect active state and local buying patterns in the current market.

Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic submission through the county's e-Procurement Portal, E-Verify compliance, drug-free workplace certification, and standard insurance coverages including workers' compensation and commercial general liability. The contract offered an initial two-year term with a one-year renewal option and included a three-month probationary termination clause. No explicit set-aside designations were noted. Without additional recent opportunities across other state and local jurisdictions, this code shows minimal documented activity suitable for business development pursuit.